These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2184650)

  • 1. Cardiovascular protective properties of indapamide.
    Campbell DB; Brackman F
    Am J Cardiol; 1990 May; 65(17):11H-27H. PubMed ID: 2184650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of indapamide on an experimental model of cerebral ischemia in hypertensive rats.
    Delbarre B; Delbarre G
    Am J Med; 1988 Jan; 84(1B):20-5. PubMed ID: 3341387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology and clinical pharmacology of indapamide.
    Campbell DB; Moore RA
    Postgrad Med J; 1981; 57 Suppl 2():7-17. PubMed ID: 7033951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of 10 years of experience with indapamide as an antihypertensive agent.
    Thomas JR
    Hypertension; 1985; 7(6 Pt 2):II152-6. PubMed ID: 4077233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
    Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D
    Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of indapamide on lipoproteins and apoproteins in ambulatory hypertensive patients.
    Aubert I; Djian F; Rouffy J
    Am J Cardiol; 1990 May; 65(17):77H-80H. PubMed ID: 2184657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of indapamide sustained release 1.5 mg in hypertension.
    Donnelly R
    Clin Pharmacokinet; 1999; 37 Suppl 1():21-32. PubMed ID: 10491730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.
    Chaffman M; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Sep; 28(3):189-235. PubMed ID: 6489195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoprotein levels during long-term treatment of hypertension with indapamide.
    Meyer-Sabellek W; Gotzen R; Heitz J; Arntz HR; Schulte KL
    Hypertension; 1985; 7(6 Pt 2):II170-4. PubMed ID: 4077236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of indapamide on left ventricular mass and function in systemic hypertension with left ventricular hypertrophy.
    Komajda M; Klimczak K; Boutin B; Brackman F; Guez D; Grosgogeat Y
    Am J Cardiol; 1990 May; 65(17):37H-42H. PubMed ID: 2139541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indapamide on phosphate metabolism and vascular reactivity.
    Plante GE; Lafreniere MC; Tam PT; Sirois P
    Am J Med; 1988 Jan; 84(1B):26-30. PubMed ID: 3277416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide.
    Ferrara LA; Rubba P; Iannuzzi A; Fasano ML
    Int J Clin Pharmacol Res; 1984; 4(5):389-93. PubMed ID: 6394516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position of indapamide, a diuretic with vasorelaxant activities, in antihypertensive therapy.
    Waeber B; Rotaru C; Feihl F
    Expert Opin Pharmacother; 2012 Jul; 13(10):1515-26. PubMed ID: 22725706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor.
    Levy BI; Duriez M; Samuel JL
    Am J Hypertens; 2001 Jan; 14(1):7-13. PubMed ID: 11206683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies.
    Nádházi Z; Dézsi CA
    Clin Drug Investig; 2016 Oct; 36(10):819-27. PubMed ID: 27405983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium and large arteries in hypertension. Effects of indapamide.
    Safar M; Laurent S; Safavian A; Pannier B; Asmar R
    Am J Med; 1988 Jan; 84(1B):15-9. PubMed ID: 3277415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of twelve-month combined therapy with perindopril and indapamide on the level of blood pressure and left ventricular hypertrophy in patients with hypertensive disease].
    Timofeeva LA; Alekhin MN; Ugriumov MO; Chumakova OS; Larina VN; Sidorenko BA
    Kardiologiia; 2006; 46(3):30-4. PubMed ID: 16710252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systemic hemodynamic evaluation of indapamide.
    Gensini G; Esente P; Giambartolomei A
    Clin Ther; 1983; 5(5):475-82. PubMed ID: 6616523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
    You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.